Peptide Dosing FAQ: Research Protocol Questions

ORYN peptide pens use a click-dose mechanism where each click delivers a precise, pre-determined amount of peptide solution. The dose per click is specified on each product page. This eliminates the reconstitution math and syringe-reading errors associated with vial-based dosing, achieving <2% dosing variance compared to 10-15% with manual methods.

Each standard ORYN peptide pen contains approximately a 30-day supply at the recommended research dose. NovaDose NAD+ cartridge duration depends on the daily dose selected. Pens should be stored at 2-8C and used within 30 days of first use.

Standard ORYN peptide pens deliver a fixed dose per click. For variable dosing, the NovaDose system allows researchers to select from multiple dose levels. For most research applications, the standard pen dose aligns with commonly published protocol dosages.

Timing depends on the specific peptide and research protocol. Growth hormone secretagogues (CJC-1295, Ipamorelin) are often studied with evening administration to align with natural GH pulsatility. BPC-157 timing is less critical in published protocols. Consult peer-reviewed literature for your specific compound.

Many published research protocols involve concurrent administration of multiple peptides (stacking). Common stacks include BPC-157 + TB-500 and CJC-1295 + Ipamorelin. Each peptide should be administered from its own pen at a different injection site. Consult published stacking protocols for specific guidance.

Store unopened pens at 2-8C (standard refrigerator temperature). Once in use, keep the pen refrigerated between administrations. Do not freeze. Protect from light. Unopened ORYN pens have a 24-month shelf life. Once opened, use within 30 days.